These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 29749488)

  • 41. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
    Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
    Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.
    Vilas-Zornoza A; Agirre X; Abizanda G; Moreno C; Segura V; De Martino Rodriguez A; José-Eneriz ES; Miranda E; Martín-Subero JI; Garate L; Blanco-Prieto MJ; García de Jalón JA; Rio P; Rifón J; Cigudosa JC; Martinez-Climent JA; Román-Gómez J; Calasanz MJ; Ribera JM; Prósper F
    Leukemia; 2012 Jul; 26(7):1517-26. PubMed ID: 22307227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antitumor action of CDK inhibitor LS-007 as a single agent and in combination with ABT-199 against human acute leukemia cells.
    Xie S; Jiang H; Zhai XW; Wei F; Wang SD; Ding J; Chen Y
    Acta Pharmacol Sin; 2016 Nov; 37(11):1481-1489. PubMed ID: 27569395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
    Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
    Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.
    Miller AL; Webb MS; Copik AJ; Wang Y; Johnson BH; Kumar R; Thompson EB
    Mol Endocrinol; 2005 Jun; 19(6):1569-83. PubMed ID: 15817653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
    Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in
    Díaz T; Rodríguez V; Lozano E; Mena MP; Calderón M; Rosiñol L; Martínez A; Tovar N; Pérez-Galán P; Bladé J; Roué G; de Larrea CF
    Haematologica; 2017 Oct; 102(10):1776-1784. PubMed ID: 28751557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasone.
    Zou D; Lv M; Chen Y; Niu T; Ma C; Shi C; Huang Z; Wu Y; Yang S; Wang Y; Wu N; Zhang Y; Ouyang G; Mu Q
    Ann Hematol; 2024 Jan; 103(1):141-151. PubMed ID: 37749318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.
    Hall CP; Reynolds CP; Kang MH
    Clin Cancer Res; 2016 Feb; 22(3):621-32. PubMed ID: 26080839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression.
    Wallington-Beddoe CT; Powell JA; Tong D; Pitson SM; Bradstock KF; Bendall LJ
    Cancer Res; 2014 May; 74(10):2803-15. PubMed ID: 24686171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia.
    Yan J; Jiang N; Huang G; Tay JL; Lin B; Bi C; Koh GS; Li Z; Tan J; Chung TH; Lu Y; Ariffin H; Kham SK; Yeoh AE; Chng WJ
    Br J Haematol; 2013 Oct; 163(1):93-103. PubMed ID: 23888996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Realgar induces apoptosis in the chronic lymphocytic leukemia cell line MEC‑1.
    Liu X; Li X; Wang L; Lv X; Chen N; Li P; Lu K; Wang X
    Mol Med Rep; 2013 Dec; 8(6):1866-70. PubMed ID: 24141727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells.
    Bindreither D; Ecker S; Gschirr B; Kofler A; Kofler R; Rainer J
    BMC Genomics; 2014 Aug; 15(1):662. PubMed ID: 25103118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment.
    Bolomsky A; Schlangen K; Schreiner W; Zojer N; Ludwig H
    J Hematol Oncol; 2016 Mar; 9():17. PubMed ID: 26935956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
    PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-proliferative effect and action mechanism of dexamethasone in human medullary thyroid cancer cell line.
    Chung YJ; Lee JI; Chong S; Seok JW; Park SJ; Jang HW; Kim SW; Chung JH
    Endocr Res; 2011; 36(4):149-57. PubMed ID: 21973234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
    Han SS; Han S; Kamberos NL
    Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells.
    Shinohara T; Urayama KY; Watanabe A; Akahane K; Goi K; Huang M; Kagami K; Abe M; Sugita K; Okada Y; Goto H; Minegishi M; Iwamoto S; Inukai T
    J Cell Mol Med; 2020 Nov; 24(22):12920-12932. PubMed ID: 33002292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity.
    Yang C; Boyson CA; Di Liberto M; Huang X; Hannah J; Dorn DC; Moore MA; Chen-Kiang S; Zhou P
    Cancer Res; 2015 May; 75(9):1838-45. PubMed ID: 25744718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.